POSSIBLE INVOLVEMENT OF OATP2B1 IN GASTROINTESTINAL TOXICITY INDUCED BY SN-38, THE ACTIVE METABOLITE OF ANTICANCER IRINOTECAN

被引：0
|
作者：
Fujita, Daichi [1 ]
Saito, Yoshimasa [2 ]
Nakanishi, Takeo [1 ]
Tamai, Ikumi [1 ]
机构：
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan
[2] Natl Canc Ctr, Dept Pharm, Tokyo, Japan
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P522
引用
收藏
页码：287 / 288
页数：2
相关论文
共 50 条
  • [21] pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells
    Kobayashi, K
    Bouscarel, B
    Matsuzaki, Y
    Ceryak, S
    Kudoh, S
    Fromm, H
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (04) : 491 - 496
  • [22] Role of Mrp3-mediated efflux in systemic exposure of SN-38, the active metabolite of irinotecan
    Kitamura, Yoshiaki
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2010, 42 : 288 - 288
  • [23] Effective irinotecan (CPT-11)-containing liposomes: Intraliposomal conversion to the active metabolite SN-38
    Sadzuka, Y
    Hirotsu, S
    Hirota, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (02): : 226 - 232
  • [24] Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy
    Irie, Kei
    Okada, Akira
    Masuda, Yoshio
    Fukushima, Keizo
    Sugioka, Nobuyuki
    Okuda, Chiyuki
    Hata, Akito
    Kaji, Reiko
    Okada, Yutaka
    Katakami, Nobuyuki
    Fukushima, Shoji
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 865 - 868
  • [25] Oatp1a/1b knockout mouse model useful for evaluating the importance of Oatp1a/1b transporters for hepatic uptake of SN-38, but not irinotecan
    Iusuf, Dilek
    Ludwig, Marion
    Elbatsh, Ahmed
    van Esch, Anita
    van de Steeg, Evita
    Wagenaar, Els
    van Tellingen, Olaf
    Schinkel, Alfred H.
    DRUG METABOLISM REVIEWS, 2011, 43 : 206 - 207
  • [26] Effect of P-Glycoprotein Modulator, Cyclosporin A, on the Gastrointestinal Excretion of Irinotecan and Its Metabolite SN-38 in Rats
    Kazuhiko Arimori
    Noriaki Kuroki
    Muneaki Hidaka
    Tomomi Iwakiri
    Keishi Yamasaki
    Manabu Okumura
    Hiroshige Ono
    Norito Takamura
    Masahiko Kikuchi
    Masahiro Nakano
    Pharmaceutical Research, 2003, 20 : 910 - 917
  • [27] Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats
    Arimori, K
    Kuroki, N
    Hidaka, M
    Iwakiri, T
    Yamasaki, K
    Okumura, M
    Ono, H
    Takamura, N
    Kikuchi, M
    Nakano, M
    PHARMACEUTICAL RESEARCH, 2003, 20 (06) : 910 - 917
  • [28] SN-38, an active metabolite of irinotecan-induced apoptosis in human hepatoma cells is involved by activation of p53
    Takeba, Yuko
    Kumai, Toshio
    Matsumoto, Naoki
    Kobayashi, Shinichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 158P - 158P
  • [29] Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2
    Itoh, T
    Itagaki, S
    Sumi, Y
    Hirano, T
    Takemoto, I
    Iseki, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 420 - 424
  • [30] Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2
    Tatsuya Itoh
    Shirou Itagaki
    Yoshinobu Sumi
    Takeshi Hirano
    Isao Takemoto
    Ken Iseki
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 420 - 424
12345